Australia's largest stock trading and investment forum Australia's #1 stock forum

NTI

Click for more information

0.00%

7.0¢ neurotech international limited

Look you can't rip into poor little Johnny, 45mins a day for 9...

First 20 Last

Share
Profile

Follow
havana19

424 Posts.

30

12/10/17

12:11

Post #: 27851340
Share

Originally posted by TerribleTadpole ↑

Ouch! No it's not conjecture. It's a very clear line of logic.

A double-blind trial requires that neither clinicians nor patients know whether the treatment they are administering or getting is the active treatment or the sham (placebo).

Now that the preliminary results have been released and has created the expectation that the treatment produces a strong improvement two things are now true:
a) Every parent, carer and clinician who sees a marked improvement knows almost for certain that they are on the active arm.
b) Every parent, carer and clinician who sees no improvement knows almost for certain that they are on the inactive arm.

The blinding is gone. Simple as that... no conspiracy required. Without the blinding every measurement and observation taken will be influenced by knowledge of what treatment is being administered.

Expand

Look you can't rip into poor little Johnny, 45mins a day for 9 weeks and no results I'd be done with it too. Jeez johnny got it hard without this forum lambasting him for not finishing the trial.

NTI Price at posting: 21.5¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

RSG

Resolute shares bounce back as second payment made to Mali government to secure workers' release

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

ADD

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

HotCopper Highlights: Your most watched stocks for Week 48, 2024

There are more pages in this discussion • 11 more messages in this thread...

First 20 Last

Add NTI (ASX) to my watchlist

(20min delay)
Last 7.0¢		Change 0.000(0.00%)		Mkt cap ! $64.55M

Open	High	Low	Value	Volume
7.1¢	7.1¢	6.5¢	$108.7K	1.612M

Buyers (Bids)

No.	Vol.	Price($)
1	10000	6.4¢

Sellers (Offers)

Price($)	Vol.	No.
7.0¢	123991	2

View Market Depth

No.	Vol.	Price($)
4	589299	0.070
1	36231	0.069
5	240000	0.068
2	255000	0.067
3	262000	0.066

Price($)	Vol.	No.
0.072	100000	1
0.074	40000	1
0.075	738582	2
0.076	90000	1
0.077	190000	3

Last trade - 16.10pm 29/11/2024 (20 minute delay)

NTI (ASX) Chart